Pharma Pressreleases

This section covers the managerial aspects in the Pharma industry.

LUNGevity launches first-of-its-kind lung cancer program to enhance clinical trial participation

Friday, April 29, 2016
PR Newswire

WASHINGTON April 29 2016 PRNewswireUSNewswire LUNGevitys new Clinical Trial Ambassador program will match potential firsttime lung cancer clinical trial participants with other lung cancer patients who have already been part of a clinical trial The program is the first of its kind for lung cancer..

Elekta\'s Latest Monaco Release Features Up to Four Times Faster Calculation Speed for Reduced Radiotherapy Planning Times

Friday, April 29, 2016
PR Newswire

TURIN Italy April 29 2016 PRNewswire Elekta is pleased to announce that Monaco version 511 the latest update to its industryleading treatment planning software is available for clinical release Realworld testing has shown that Monaco version 511 provides significant performance speed enhancement..

CyTuVax Reports Interim Results of the Phase I Clinical Trial with the HBAI20 Hepatitis B Vaccine for Non-Responders

Friday, April 29, 2016

CyTuVax a life science company focusing on the development of cancer and viral vaccines today reported the interim results of a phase I clinical trial assessing the safety and efficacy of its lead product a Hepatitis B HBAI20 vaccine for nonresponders The interim analysis shows that a combination of..

Advanced Accelerator Applications reports 26.8% sales growth in 2015 and continues to show significant clinical progress across both therapeutic and diagnostic platforms

Friday, April 29, 2016
GLOBE NEWSWIRE

2015 Highlights Reported a yearonyear increase in sales of 268 for the fullyear and 14 for the fourth quarter of 2015Completed an IPO and listed on the Nasdaq Global Select Market under the ticker AAAPPresented favorable results of pivotal Phase III trial NETTER1 for Lutathera for the treatment..

NewLink Genetics Reports First Quarter 2016 Financial Results

Friday, April 29, 2016
GLOBE NEWSWIRE

IMPRESS Phase 3 Topline Results Now Expected in Second Quarter of 2016Pancreatic and Melanoma IDO Pathway Inhibitor Trial Updates at ASCO Management to Host Conference Call Today at 830 am ET AMES Iowa and AUSTIN Texas April 29 2016 GLOBE NEWSWIRE NewLink Genetics Corporation NASDAQNLNK a b..

Arbutus to Provide a Corporate Update and Release First Quarter 2016 Financial Results

Friday, April 29, 2016
GLOBE NEWSWIRE

VANCOUVER British Columbia and DOYLESTOWN Pa April 29 2016 GLOBE NEWSWIRE Arbutus Biopharma Corporation NasdaqABUS an industryleading Hepatitis B Virus HBV therapeutic solutions company today announced that it will hold a conference call and webcast on Wednesday May 4 2016 at 130 pm Pacific Ti..

Oncolytics Biotech® Inc. Announces Formation of Science and Technology Committee

Friday, April 29, 2016
PR Newswire

CALGARY April 29 2016 PRNewswire Oncolytics Biotech Inc TSX ONC OTCQX ONCYF FRA ONY Oncolytics or the Company today announced the formation of a Science and Technology Committee made up of directors Dr William Rice and Dr Bernd Seizinger In addition to many years of senior leadership in oncology ..

BioDelivery Sciences Announces Acceptance of an Abstract to the International Conference on Opioids on the Impact of a State Formulary Conversion to BUNAVAIL

Friday, April 29, 2016
PR Newswire

RALEIGH NC April 29 2016 PRNewswire BioDelivery Sciences International Inc NASDAQ BDSI announced the acceptance of an abstract for presentation at the International Conference on Opioids which takes place June 57 2016 in Boston Massachusetts The abstract entitled Reduced BuprenorphineNaloxone Pres..

Shire Delivers Strong Q1 2016 Results With Double-digit Growth in Revenue and Non GAAP Earnings Per ADS

Friday, April 29, 2016
PR Newswire

DUBLIN April 29 2016 PRNewswire Shire plc Shire LSE SHP NASDAQ SHPG announces unaudited results for the three months ended March 31 2016 Financial Highlights Q1 2016 Growth1 Non GAAP CER12 Product sales 1627 million 14 16 Total revenues 1709 million 15 17 N..

Can-Fite to Present at Joseph Gunnar & Co.\'s Pioneers 2016 Conference in New York City on May 5, 2016

Friday, April 29, 2016
PR Newswire

PETACH TIKVA Israel April 29 2016 PRNewswire CanFite BioPharma Ltd NYSE MKT CANF TASE CFBI a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory diseases cancer and sexual dysfunction today announced the Companys Chief Financial Officer Motti Farbst..

Valeant Pharmaceuticals Files Annual Report On Form 10-K For Year Ended December 31, 2015

Friday, April 29, 2016
PR Newswire

LAVAL Quebec April 29 2016 PRNewswire Valeant Pharmaceuticals International Inc Valeant or the Company NYSE VRX TSX VRX today announced that it has filed with the US Securities and Exchange Commission the SEC its Annual Report on Form 10K for the fiscal year ended December 31 2015 the Form 10K Thi..

Solid Performance in the First Quarter of 2016 with Business EPS up 5.3% at Constant Exchange Rates

Friday, April 29, 2016
PR Newswire

PARIS April 29 2016 PRNewswire Sanofi NYSE SNY EURONEXT SAN Experience the interactive Multimedia News Release here httpwwwmultivucomplayersEnglish7788751sanofiearningsresultsq12016 Q1 2016 Change Change CER Aggregate Group sales1 8543m 19 07 Business net income2 1722m ..

AbbVie to Present at the Bank of America Merrill Lynch 2016 Global Health Care Conference

Friday, April 29, 2016
PR Newswire

NORTH CHICAGO Ill April 29 2016 PRNewswire AbbVie NYSE ABBV will participate in the Bank of America Merrill Lynch 2016 Global Health Care Conference on Thursday May 12 2016 Bill Chase executive vice president and chief financial officer will participate in a question and answer session at 120 pm ..

SCILEX Pharmaceuticals Announces Addition of Bob Rappaport, M.D., to Scientific Advisory Board

Friday, April 29, 2016
PR Newswire

MALVERN Pa April 29 2016 PRNewswire SCILEX Pharmaceuticals Inc a company engaged in the development and commercialization of products focused on the treatment of pain today announced the addition of Bob Rappaport MD to its Scientific Advisory Board Dr Rappaport has more than 30 years of medical..

Heritage Pharmaceuticals Issues Product Safety Warning Due to Reported Sales of Counterfeit Drug Product Labeled as BiCNU® (Carmustine for Injection) 100mg Outside of the United States

Friday, April 29, 2016
PR Newswire

EATONTOWN NJ April 29 2016 PRNewswire Heritage Pharmaceuticals Inc Heritage today announced that it recently became aware of the existence of a counterfeit drug product labeled as BiCNU Carmustine for Injection 100mg that has been sold and distributed outside of the United States BiCNU is prima..

LUNGevity launches first-of-its-kind lung cancer program to enhance clinical trial participation

Friday, April 29, 2016
PR Newswire

WASHINGTON April 29 2016 PRNewswireUSNewswire LUNGevitys new Clinical Trial Ambassador program will match potential firsttime lung cancer clinical trial participants with other lung cancer patients who have already been part of a clinical trial The program is the first of its kind for lung cancer..

SQI Diagnostics to Announce Second Quarter 2016 Results

Friday, April 29, 2016
PR Newswire

TORONTO April 29 2016 PRNewswire SQI Diagnostics Inc SQI Diagnostics or the Company TSXV SQD OTCQX SQIDF today announced that it plans to release its financial and operational results for the three and six months ended March 31 2016 at 830am EST Friday May 13 2016 President and CEO Andrew Morris ..

Biocept, Inc. Announces Pricing Of $5 Million Public Offering Of Common Stock And Warrants

Friday, April 29, 2016
PR Newswire

SAN DIEGO April 29 2016 PRNewswire Biocept Inc Biocept Nasdaq BIOC today announced that it has priced a registered public offering of an aggregate of approximately 50 million shares of common stock at a price to the public of 100 per share Investors will also receive warrants to purchase up to an..

Allergan Receives CHMP Positive Opinion For ENZEPI® (Pancrelipase) For Patients With Exocrine Pancreatic Insufficiency (EPI)

Friday, April 29, 2016
PR Newswire

DUBLIN April 29 2016 PRNewswire Allergan plc NYSE AGN a leading global pharmaceutical company today announced that the Committee for Medicinal Products for Human Use CHMP has adopted a Positive Opinion for the Marketing Authorisation of ENZEPI pancrelipase in the European Union 1 ENZEPI is a pancr..

aTyr Pharma to Present at Upcoming May Investor Conferences

Friday, April 29, 2016
PR Newswire

SAN DIEGO April 29 2016 PRNewswire aTyr Pharma Inc Nasdaq LIFE a biotherapeutics company engaged in the discovery and development of Physiocrinebased therapeutics to address severe rare diseases today announced the Companys participation in two upcoming investor conferences John Mendlein PhD aTyrs..

TOP